









Mercados
/
Ações
/
nasdaq-qdel
/

QuidelOrtho Corp

QDEL

29.100USD

+0.410+1.43%

Fechamento 02/06, 16:00（ET）Cotações atrasadas em 15 min

1.98BValor de mercado

PerdaP/L TTM



QuidelOrtho Corp

29.100

+0.410+1.43%

Visão Geral Serviços Financeiros Análises Empresa

Visão Geral

Serviços Financeiros

Análises

Empresa

Mais detalhes de QuidelOrtho Corp Empresa

QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics and Ortho Optix.

Informações de QuidelOrtho Corp



Código da empresaQDEL

Nome da EmpresaQuidelOrtho Corp

Data de listagemFeb 01, 1991

CEOBlaser (Brian J)

Número de funcionários6600

Tipo de títulosOrdinary Share

Fim do ano fiscalFeb 01

Endereço9975 Summers Ridge Road

CidadeSAN DIEGO

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal92121

Telefone18585521100

Sitehttps://www.quidelortho.com/

Código da empresaQDEL

Data de listagemFeb 01, 1991

CEOBlaser (Brian J)

Executivos da empresa QuidelOrtho Corp



Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9215.00%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+4929.00%

Mr. Joseph M. Busky

Chief Financial Officer

39.40K

+5823.00%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

38.99K

+6959.00%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

25.14K

+13691.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+5650.00%

Ms. Ann D. Rhoads

Independent Director

15.02K

+750.00%

Mr. John R. Chiminski

Independent Director

2.52K

+2523.00%

Dr. Mary Lake Polan, M.D., Ph.D.

Independent Director

Dr. Kenneth Jon (Ken) Widder, M.D.

Independent Director

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Dr. Kenneth F. Buechler, Ph.D.

Independent Chairman of the Board

104.41K

+9215.00%

Dr. Matthew W. Strobeck, Ph.D.

Independent Director

72.55K

+4929.00%

Mr. Joseph M. Busky

Chief Financial Officer

39.40K

+5823.00%

Ms. Michelle A. Hodges, J.D.

Senior Vice President, Corporate Secretary, Chief Legal Officer

38.99K

+6959.00%

Mr. Brian J. Blaser

President, Chief Executive Officer, Director

25.14K

+13691.00%

Mr. Edward L. (Ed) Michael

Independent Director

21.35K

+5650.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por EmpresaUSD

Nome

Receita

Proporção

Labs

373.80M

53.41%

Point-of-Care

164.60M

23.52%

Immunohematology

142.00M

20.29%

Donor Screening

14.70M

2.10%

Molecular Diagnostic Solutions

4.80M

0.69%

Por RegiãoUSD

Nome

Receita

Proporção

North America

381.40M

54.49%

Other

142.10M

20.30%

EMEA

91.80M

13.12%

China

84.60M

12.09%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Labs

373.80M

53.41%

Point-of-Care

164.60M

23.52%

Immunohematology

142.00M

20.29%

Donor Screening

14.70M

2.10%

Molecular Diagnostic Solutions

4.80M

0.69%

Distribuição de ações

Atualizado em: seg, 17 de nov

Investidores

Tipos de investidores

Investidores

Proporção

T. Rowe Price Investment Management, Inc.

16.21%

BlackRock Institutional Trust Company, N.A.

13.72%

The Vanguard Group, Inc.

11.09%

Rubric Capital Management LP

6.83%

Fidelity Management & Research Company LLC

6.54%

Outro

45.61%

Investidores

Proporção

T. Rowe Price Investment Management, Inc.

16.21%

BlackRock Institutional Trust Company, N.A.

13.72%

The Vanguard Group, Inc.

11.09%

Rubric Capital Management LP

6.83%

Fidelity Management & Research Company LLC

6.54%

Outro

45.61%

Tipos de investidores

Investidores

Proporção

Investment Advisor

68.38%

Investment Advisor/Hedge Fund

35.50%

Hedge Fund

14.78%

Research Firm

2.25%

Pension Fund

1.00%

Individual Investor

1.00%

Private Equity

0.71%

Bank and Trust

0.55%

Sovereign Wealth Fund

0.52%

Participação acionária institucional



Atualizado em: qui, 1 de jan

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q4

657

83.91M

123.52%

-20.38M

2025Q3

656

79.44M

116.95%

-23.17M

2025Q2

684

78.51M

115.63%

-21.42M

2025Q1

726

76.59M

113.26%

-21.60M

2024Q4

747

75.07M

111.30%

-13.02M

2024Q3

744

73.58M

109.44%

-4.02M

2024Q2

767

70.18M

104.79%

-7.57M

2024Q1

799

67.05M

100.24%

-5.28M

2023Q4

828

68.21M

102.09%

-2.95M

2023Q3

842

70.19M

105.17%

-4.01M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

T. Rowe Price Investment Management, Inc.

11.01M

16.21%

-124.03K

-1.11%

Sep 30, 2025

BlackRock Institutional Trust Company, N.A.

9.32M

13.72%

+39.16K

+0.42%

Sep 30, 2025

The Vanguard Group, Inc.

7.60M

11.19%

-165.71K

-2.13%

Sep 30, 2025

Rubric Capital Management LP

4.64M

6.83%

Sep 30, 2025

Fidelity Management & Research Company LLC

4.44M

6.54%

+1.89M

+73.81%

Sep 30, 2025

Dimensional Fund Advisors, L.P.

2.86M

4.21%

+350.64K

+13.98%

Sep 30, 2025

Newtyn Management, LLC

2.70M

3.97%

+994.33K

+58.30%

Sep 30, 2025

State Street Investment Management (US)

2.67M

3.93%

-32.20K

-1.19%

Sep 30, 2025

Invesco Advisers, Inc.

2.66M

3.92%

+1.33M

+100.02%

Sep 30, 2025

American Century Investment Management, Inc.

2.12M

3.11%

+199.91K

+10.44%

Sep 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: ter, 2 de dez

Nome

Proporção

State Street SPDR S&P Health Care Equipment ETF

1.75%

Invesco S&P SmallCap Health Care ETF

1.12%

Ballast Small/Mid Cap ETF

0.94%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.56%

JPMorgan Fundamental Data Science Small Core ETF

0.35%

State Street SPDR S&P 600 Small Cap Value ETF

0.26%

Avantis US Small Cap Value ETF

0.26%

iShares S&P Small-Cap 600 Value ETF

0.25%

iShares U.S. Medical Devices ETF

0.22%

State Street SPDR S&P SmallCap 600 ESG ETF

0.19%

Ver Mais

State Street SPDR S&P Health Care Equipment ETF

Proporção1.75%

Invesco S&P SmallCap Health Care ETF

Proporção1.12%

Ballast Small/Mid Cap ETF

Proporção0.94%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporção0.56%

JPMorgan Fundamental Data Science Small Core ETF

Proporção0.35%

State Street SPDR S&P 600 Small Cap Value ETF

Proporção0.26%

Avantis US Small Cap Value ETF

Proporção0.26%

iShares S&P Small-Cap 600 Value ETF

Proporção0.25%

iShares U.S. Medical Devices ETF

Proporção0.22%

State Street SPDR S&P SmallCap 600 ESG ETF

Proporção0.19%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Data ex-dividendo

Tipo

Proporção

Sem dados

Data

Data ex-dividendo

Tipo

Proporção

Sem dados

KeyAI

